Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2026-01-03 @ 11:30 PM
Study NCT ID:
NCT03531957
Status:
COMPLETED
Last Update Posted:
2023-07-03
First Post:
2018-04-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Sponsor:
Asana BioSciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08-14
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-19
First Submit QC Date:
None
Study First Post Date:
2018-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-05-20
Results First Submit QC Date:
None
Results First Post Date:
2022-11-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-28
Last Update Post Date:
2023-07-03
Last Update Post Date Type:
ACTUAL